Hamburg, April 2017 The product line sealed with the new purity grade “Eppendorf Forensic DNA Grade” complies with the stringent requirements of the recently released ISO18385. This standard specifies the demands on manufacturers of products which are used in forensic DNA laboratories to further minimize the risk of contamination. Eppendorf confirms the compliance for every... Read more
The Ochra-V AQUA eliminates the use of organic solvents while also significantly reducing testing time MILFORD, Mass.–(BUSINESS WIRE)–Apr. 19, 2017– Waters Corporation (NYSE:WAT) announced VICAM®, a Waters® Business, now offers a rapid, eco-friendly lateral flow strip test specifically for the detection of ochratoxin A in green coffee and wheat. Compared to traditional methods, the Ochra-V®... Read more
Basel, 19 April 2017 Roche to present new data at AAN reinforcing efficacy and safety of newly FDA-approved OCREVUS™ (ocrelizumab) in two types of multiple sclerosis Data presentations will include platform sessions and posters across relapsing multiple sclerosis and primary progressive multiple sclerosis Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that new data on... Read more
Order Contact Careers Account Log In/Register Why CDI Partners & Providers Our Technology Cellular Therapy Drug Discovery Health & Nutrition Stem Cell Banking Products & Services iCell Products iCell Cardiomyocytes iCell Cardiomyocytes2 iCell Cardiac Progenitor Cells iCell Neurons iCell Astrocytes iCell DopaNeurons iCell GlutaNeurons iCell Hepatocytes 2.0 iCell Hepatoblasts iCell Skeletal Myoblasts iCell Endothelial Cells... Read more
Thermo Scientific NextGuard Pro enables inspection/detection of up to 50 kg/110 lbs in IP65 plants MINNEAPOLIS, April 18, 2017 /PRNewswire/ — A new X-ray machine from Thermo Fisher Scientific engineered to handle heavy product weights of up to 50 kilograms/110 pounds in IP65 washdown environments will make its debut at Interpack 2017, May 4-10 in Düsseldorf,... Read more
Basel, 18 April 2017 FDA approves Roche’s Lucentis (ranibizumab injection) for diabetic retinopathy, the leading cause of blindness among working age adults in the United States First and only medicine approved to treat all forms of diabetic retinopathy Granted Priority Review Designation by the FDA based on analysis of results from a National Institutes of... Read more
Basel, 18 April 2017 FDA approves Roche’s Lucentis (ranibizumab injection) for diabetic retinopathy, the leading cause of blindness among working age adults in the United States First and only medicine approved to treat all forms of diabetic retinopathy Granted Priority Review Designation by the FDA based on analysis of results from a National Institutes of... Read more
Basel, 18 April 2017 FDA grants Roche’s TECENTRIQ® (atezolizumab) accelerated approval as initial treatment for certain people with advanced bladder cancer First and only cancer immunotherapy approved in advanced bladder cancer as initial treatment for those unable to receive cisplatin chemotherapy Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug... Read more
RADNOR, Pa., April 18, 2017 /PRNewswire/ — VWR (NASDAQ: VWR), the leading global independent provider of product and service solutions to laboratory and production facilities, has been recognized by E&I Cooperative Services (E&I) with the 2017 Partner of the Year award. VWR was honored as a result of its proactive approach to providing products and services... Read more